← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2002Last known activity
Aug 1, 2008
Defunct as of May 1, 2016
Timeline
2000s
- Jun 1, 2002
Symphony Capital— Founded
2010s
- May 1, 2016
Symphony Capital— Defunct
Drugs by trial phase (3 distinct, 12 trials)
Indications
Studied for
- Albuminuria
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Diabetic Nephropathies
- Erectile Dysfunction
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Parkinson Disease
- Prostatic Neoplasms
Recent trials (13)
- NCT00955084Lead sponsorPhase 1Aug 1, 2008
- NCT00955084Study directorPhase 1Aug 1, 2008
- NCT00491699Lead sponsorPhase 1Aug 1, 2007
- NCT00322673Lead sponsorPhase 2May 1, 2006
- NCT00312780Lead sponsorPhase 2Mar 1, 2006
- NCT00304590Lead sponsorPhase 2Feb 1, 2006
- NCT00277290Lead sponsorPhase 2Jan 1, 2006
- NCT00277329Lead sponsorPhase 2Dec 1, 2005
- NCT00277303Lead sponsorPhase 2Dec 1, 2005
- NCT00277316Lead sponsorPhase 2Dec 1, 2005
- NCT00104117Lead sponsorPhase 1Nov 1, 2004
- NCT00090376CollaboratorPhase 2Dec 1, 2003
- NCT00209508CollaboratorPhase 2Nov 1, 2002
Details
- Founded
- New York, NY, US Jun 1, 2002
- Last known activity
- Aug 1, 2008
Notes
--- Notes from Symphony Evolution, Inc.: No evidence it is still active --- --- Notes from Symphony Health Solutions: CRO ---